Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-01-04
2005-01-04
Weber, Jon P. (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S773000, C514S775000, C514S780000, C514S783000, C530S360000, C530S370000, C426S590000
Reexamination Certificate
active
06838431
ABSTRACT:
The invention relates to a nutritional intervention composition in powder form that is taken before a meal and that extends post meal satiety. The compositions of the invention are comprised of at least one protein, C12-18fatty acids, preferably oleic acid, all of which stimulate CCK release in the body, and a source of proteinase inhibitor which acts to prevent the deactivation of CCK. The subject compositions preferably additionally contain a source of calcium and are advantageous in that they utilize a source of proteinase inhibitor as opposed to the more costly extracts. The source of proteinase inhibitor is advantageously an extract of potato, soy, or beans containing about 10 weight percent of proteinase inhibitor. The powder compositions are mixed with a suitable liquid, preferably water, prior to ingestion.
REFERENCES:
patent: 4491578 (1985-01-01), Peikin
patent: 4833128 (1989-05-01), Solomon et al.
patent: 5086042 (1992-02-01), Rosamond
patent: 5221668 (1993-06-01), Henningfield et al.
patent: 5340603 (1994-08-01), Neylan et al.
patent: 5468727 (1995-11-01), Phillips et al.
patent: 5750353 (1998-05-01), Kopin et al.
patent: 5814316 (1998-09-01), Cook et al.
patent: 5827517 (1998-10-01), Cook et al.
patent: 5932561 (1999-08-01), Meyers et al.
patent: 5989584 (1999-11-01), Cook et al.
patent: 6355612 (2002-03-01), Ballevre et al.
patent: 6429190 (2002-08-01), Portman
patent: 6436899 (2002-08-01), Portman
Calam J. Bojarski JC and Springer CJ. Raw soybean flour increases cholecystokinin release in man.Br J of Nutr58:175-179, 1987., Abstract only.
Debas HT, Farooq O and Grossman MI. Inhibition of gastric emptying is a physiological action of cholecystokinin.Gastroenterology68:1211-1217, 1975., Abstract only.
Dlugosz J. Folsch VR and Creutzfeldt W Inhibition of intraduodenal typsin does not stimulate exocrine pancreatic secretion in man.Digestion26:197-204, 1983., Abstract only.
Geracioti TA Jr, Liddle RA. Impaired cholecystokinin secretion in bulimia nervosa.N Engl J Med319:683-688, 1988., abstract only.
Gibbs J, Falasco JD and McHugh PR. Cholecystokinin-decreased food intake in Rhesus monkeys.Am J Physiol230:15-18, 1976.
Green GM and Lyman RL. Chymotrypsin inhibitor stimulation of pancreatic enzyme secretion in the rat.Proc Soc Exp Biol Med136:649-654, 1971.
Green GM and Lyman RL. Feedback regulation of pancreatic enzyme secretion as a mechanism for trypsin inhibitor-induced hypersecretion in rats.Proc Soc Exp Biol Med140:6-12, 1972.
Hill AJ, Peikin SR, Ryan CA, Blundell, JE. Oral administration of proteinase inhibitor II from potatoes reduces energy intake in man.Physiol Behav48(2):241-246, 1990.
Kissileff HR, Pi-Sunyer HR, Thornton I and Smith GP: C-terminal octapeptide of cholecystokinin decreases food intake in man,Am J Clin Nutrition34:154-60, 1981., Abstract only.
Pi-Sunyer X, Kissileff HR, Thornton J and Smith GP. C-terminal octapeptide of Cholecystokinin decreases food intake in obese men.Physiol Behav29(4) 627-630, 1982.
Stacher G, Bauer H and Steinringer H. Cholecystokinin decreases appetite and activation evoked by stimuli arising from the preparation of a meal in man.Physiol Behav 23:325-331, 1979.
Stacher, G; Steinringer, H.; Schneider, C.; Winklehner, S. Cholecystokinin octapeptide decreases intake of solid food in man.Peptides3:2, 133-136, 1982., abstract only.
Bryant, Proteinase Inhibitor II from Potatoes: Isolation and Characterization of Its Promoter Components, Biochemistry, vol. 15, No. 16 34 18-24, 1976.
McCarthy, Complementary Measures for Promoting Insulin Sensitivity In Skeletal Muscle, Medical Hypotheses, vol. 51(6), p451-464, 1998., abstract only.
Campbell, Effects of Resistance Training and Chromium Picolinate on Body Composition and Skeletal Muscle in Older Men, Journal of Applications of Physiology, vol. 86(1). p29-39, 1999., abstract only.
Spiegel, Effect of a Premeal Beverage Containing a Protease Inhibitor from Potatoes on Satiety in Dieting Overweight Women (unpublished abstract)., abstract only.
Vasselli, Consumption of a Pre-Meal Drink Containing Pretease Inhibitor from Potatoes Decreases Hunger and Increases Fullness in Overweight Subjects Following a Meal (unpublished abstract).
Dawson-Hughes B., Dallal G.E., Krall, E.A, Sadowski, L., Sahyoun N., Tannenbaum, S., A Controlled Trial of the Effect of Calcium SupPlementation on Bone Density in Postmenopausal Women. N Engl J Med., 1990 Sep. 27;323(13):878-83.
Gibbons, Del Deo, Dolan Griffinger and Vecchione
Kam Chih-Min
Kemin Consumer Care, L.C.
Pacific Health Laboratories, Inc.
Weber Jon P.
LandOfFree
Nutritional intervention composition containing a source of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nutritional intervention composition containing a source of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nutritional intervention composition containing a source of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3371831